Vaxinano Email Format
Biotechnology ResearchHauts-de-france, France11-50 Employees
Vaxinano is a french biotechnology company, developing a new generation of vaccines that are more efficient and faster to deploy to prevent or treat infectious diseases. The vaccine platform is based on Stellar-NP technology that confer highly stable, adjuvant-free vaccine for an effective and long-lasting response to protect against the most difficult pathogens, such as parasites, viruses, bacteria or fungi.